In vivo priming of two distinct antitumor effector populations: The role of MHC class I expression

Keyphrases

• Antitumor 100%
• In Vivo Priming 100%
• MHC-I 100%
• Tumor 50%
• Granulocyte Colony-stimulating Factor (G-CSF) 20%
• Tumor Challenge 20%
• Natural Killer Cells 20%
• CD8+ T Cells 20%
• Therapeutic Vaccine 10%
• CD4+ T 10%
• Immune Response 10%
• Tumor Cells 10%
• Effector Cells 10%
• CD4+ 10%
• Immunization 10%
• Protective Response 10%
• Major Histocompatibility Complex 10%
• T-cell Mediated 10%
• Active Immunization 10%
• Systemic Antitumor Immune Response 10%
• Complex Expressions 10%
• Addition-elimination 10%
• Evade 10%

Immunology and Microbiology

• Major Histocompatibility Complex 100%
• Immune Response 18%
• T-Helper Cell 18%
• Natural Killer Cell 18%
• Granulocyte Macrophage Colony-Stimulating Factor 18%
• Cytotoxic T-Cell 18%
• T Cell 9%
• Tumor Cell 9%
• Downregulation 9%
• Effector Cell 9%
• Tumor Vaccine 9%
• Active Immunization 9%